Endothelin-1 in Subarachnoid Hemorrhage
- 1 December 2000
- journal article
- research article
- Published by Wolters Kluwer Health in Stroke
- Vol. 31 (12) , 2971-2975
- https://doi.org/10.1161/01.str.31.12.2971
Abstract
Background and Purpose—The most potent vasoconstrictor known, endothelin-1, is currently considered to mediate cerebral vasospasm in subarachnoid hemorrhage (SAH), which can cause delayed cerebral ...Keywords
This publication has 33 references indexed in Scilit:
- Antisense preproendothelin-oligoDNA therapy for vasospasm in a canine model of subarachnoid hemorrhageJournal of Neurosurgery, 1999
- ?ndothelin: new discoveries and rapid progress in the clinicTrends in Pharmacological Sciences, 1998
- ANNOUNCEMENTNeurosurgery, 1997
- Intracranial AneurysmsNew England Journal of Medicine, 1997
- QUANTITATIVE PCR ANALYSIS OF CYTOKINE TRANSCRIPTION PATTERNS IN PERIPHERAL MONONUCLEAR CELLS AFTER ANTI-CD3 REJECTION THERAPY USING TWO NOVEL MULTISPECIFIC COMPETITOR FRAGMENTS1Transplantation, 1994
- The role of endothelin-1 in the origin of cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhageJournal of Neurosurgery, 1992
- The biosynthesis of endothelin-1 by human polymorphonuclear leukocytesBiochemical and Biophysical Research Communications, 1991
- Endothelin Immunoreactivity in Cerebrospinal Fluid of Patients with Subarachnoid HaemorrhageAnnals of Medicine, 1990
- Endothelin and the production of cerebral vasospasm in dogsBiochemical and Biophysical Research Communications, 1989
- Transcranial doppler ultrasound for the assessment of intracranial arterial flow velocity—Part 1. Examination technique and normal valuesSurgical Neurology, 1987